177 related articles for article (PubMed ID: 22508675)
1. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification.
Horne MJ; Chhieng DC; Theoharis C; Schofield K; Kowalski D; Prasad ML; Hammers L; Udelsman R; Adeniran AJ
Diagn Cytopathol; 2012 May; 40(5):410-5. PubMed ID: 22508675
[TBL] [Abstract][Full Text] [Related]
2. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
Faquin WC; Baloch ZW
Diagn Cytopathol; 2010 Oct; 38(10):731-9. PubMed ID: 20049964
[TBL] [Abstract][Full Text] [Related]
3. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
Wu HH; Rose C; Elsheikh TM
Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
[TBL] [Abstract][Full Text] [Related]
4. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
5. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification.
Ustun B; Chhieng D; Van Dyke A; Carling T; Holt E; Udelsman R; Adeniran AJ
Cancer Cytopathol; 2014 Jul; 122(7):536-45. PubMed ID: 24753500
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
10. Follicular lesion of undetermined significance in thyroid FNA revisited.
Walts AE; Mirocha J; Bose S
Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
[TBL] [Abstract][Full Text] [Related]
11. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology?
Yang SE; Sullivan PS; Zhang J; Govind R; Levin MR; Rao JY; Moatamed NA
Cancer Cytopathol; 2016 Feb; 124(2):100-9. PubMed ID: 26422098
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System.
Lale SA; Morgenstern NN; Chiara S; Wasserman P
Diagn Cytopathol; 2015 Aug; 43(8):598-604. PubMed ID: 25728981
[TBL] [Abstract][Full Text] [Related]
13. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations.
Yang J; Schnadig V; Logrono R; Wasserman PG
Cancer; 2007 Oct; 111(5):306-15. PubMed ID: 17680588
[TBL] [Abstract][Full Text] [Related]
14. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study.
Bongiovanni M; Crippa S; Baloch Z; Piana S; Spitale A; Pagni F; Mazzucchelli L; Di Bella C; Faquin W
Cancer Cytopathol; 2012 Apr; 120(2):117-25. PubMed ID: 21998003
[TBL] [Abstract][Full Text] [Related]
16. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
17. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Jo VY; Stelow EB; Dustin SM; Hanley KZ
Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
[TBL] [Abstract][Full Text] [Related]
18. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies.
Marchevsky AM; Walts AE; Bose S; Gupta R; Fan X; Frishberg D; Scharre K; Zhai J
Diagn Cytopathol; 2010 Apr; 38(4):252-9. PubMed ID: 19813257
[TBL] [Abstract][Full Text] [Related]
20. Implications of the proposed thyroid fine-needle aspiration category of "follicular lesion of undetermined significance": A five-year multi-institutional analysis.
Layfield LJ; Morton MJ; Cramer HM; Hirschowitz S
Diagn Cytopathol; 2009 Oct; 37(10):710-4. PubMed ID: 19373907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
